July 29 (Reuters) - Flerie AB FLERIE.ST :
* PURCHASED 111,276 SHARES IN XSPRAY PHARMA FOR APPROX. SEK
5.6
MILLION AND NOW OWNS 17.5 % OF SHARES IN COMPANY
* REMAINS FIRM IN BELIEF THAT THERE IS SIGNIFICANT
COMMERCIAL
POTENTIAL IN XSPRAY AND ITS TECHNOLOGY PLATFORM
* REMAINS FULLY COMMITTED TO XSPRAY AND IS CONFIDENT THAT
COMPANY
WILL BE ABLE TO REACH US MARKET WITH DASYNOC
Source text for Eikon: ID:nMFN8SNDWB
Further company coverage: FLERIE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))